8:00 am Check -In & Breakfast Networking Session

9:00 am Workshop A: Narrowing the Translatability Gap

Overcoming Species-Specific Limitations in Preclinical Models for Human Disease

• Paul Ashton Chief Executive Officer, Inflammasome Therapeutics
• Alan Watt President & Chief Scientific Officer, NodThera Ltd.

12:00 pm Lunch Break & Networking

1:00 pm Workshop B: Establishing the Correct Endpoints

Highlighting the Bottlenecks & Solutions for Inflammasome Target Indication Assessment

• Lauren Martens Vice President, Biology, Neumora Therapeutics, Inc.
• Nick Brandon Chief Scientific Officer, Neumora Therapeutics, Inc.

4:00 pm End of Pre-Conference Workshop Day